About
Approach
Investment Model
Investment Scope
Our approach
Team
Managing Partner
Partners
Our team
Portfolio
News
Connect
Pages
Pages
Home
About
Blog
Blog Post
Contact
Portfolio
Investors
Investor Single
Shop
Shop Single
Utility Pages
Start Here
Style Guide
404 Not Found
Password Protected
Licenses
Changelog
Browse More Templates
IMG-004 demonstrated extended half-life and durable pharmacodynamic characteristics in a Phase 1 study
Article Date
April 28, 2023
This article is featured on another website.
Go to article
Related posts
Browse all articles
May 12, 2026
HiRO Is Attending DIA China 2026: Meet Us in Shanghai
Visit HiRO at Booth TF01 to discuss Modern, Disciplined CRO Solutions HiRO is excited to…
May 12, 2026
HiRO Is Attending DIA China 2026: Meet Us in Shanghai
Visit HiRO at Booth TF01 to discuss Modern, Disciplined CRO Solutions HiRO is excited to…
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics